People who originally received the Johnson & Johnson vaccine benefited significantly more from a messenger RNA booster than a second J&J dose.
Related posts:
Supreme Court agrees to hear first abortion case with 6-3 conservative majority
U.S. must confront Covid spike, noted epidemiologist warns
Lack of vaccine capacity propels Canada into global race to attract drug companies
The most promising coronavirus vaccine you’ve never heard of
Poll: Slim majority in U.S. backs return of masking
HHS unveils office to treat climate change as a health issue
Drug industry banks on its Covid clout to halt Dems’ push on prices
The political fallout of Texas’ abortion ban
Too early to know answers on Omicron variant, NIH director says
World Health Organization criticizes travel bans on southern African countries
Pfizer says its booster shot can protect against Omicron
Chicago mayor tests positive for Covid a day after announcing school reopening deal
